Stability of lipid excipients in solid lipid nanoparticles

Advanced Drug Delivery Reviews

Volumn 59, Issue 6, 2007, Pages 411-418

  Radomska Soukharev, Anna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

High pressure homogenization; Lipid excipients; Physico chemical stability; SLN; Solid lipid nanoparticles; Surfactants

Indexed keywords

HIGH PRESSURE HOMOGENIZATION; LIPID EXCIPIENTS; PHYSICO-CHEMICAL STABILITY; SOLID LIPID NANOPARTICLES;

CONCENTRATION (PROCESS); GAS CHROMATOGRAPHY; NANOPARTICLES; SURFACE ACTIVE AGENTS;

LIPIDS;

CHOLIC ACID; DODECYL SULFATE SODIUM; DYNASAN 112; DYNASAN 114; DYNASAN 116; DYNASAN 118; EMULSIFYING AGENT; EXCIPIENT; GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; IMWITOR 900; LIPID; POLYSORBATE 80; SOFTISAN 138; SOFTISAN 142; SOFTISAN 155; SOLID LIPID NANOPARTICLE; TAGAT S; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WITEPSOL S 51; WITEPSOL S 55;

CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG STABILITY; GAS CHROMATOGRAPHY; LASER DIFFRACTION; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; REVIEW; ZETA POTENTIAL;

CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, GAS; DRUG CARRIERS; DRUG STABILITY; EXCIPIENTS; LIPIDS; NANOPARTICLES; PARTICLE SIZE; SURFACE-ACTIVE AGENTS;

EID: 34547913461     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.04.004     Document Type: Review

References (23)

1. Peters K., and Müller R.H. Nanosuspensions for the oral administration of poorly soluble drugs. European Symposium on formulation of Poorly-available Drugs for Oral Administration (1996), APGI, Paris 330-333
2. Mu{double acute}ller R.H., Mäder K., and Gohla S. Solid Lipid Nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 50 (2000) 161-177
3. Mu{double acute}ller R.H., and Mehnert K. Solid Lipid Nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 41 (1995) 62-69
4. M.R., Gasco, European Patent 0526666 A 1 (1991)
5. P. Speiser, European Patent EU 0166725 (1991)
6. Food Drug Cosmetic Reports (1994), Commerce Clearing House Inc.
7. Mu{double acute}ller R.H., Weyhers H., Mu{double acute}hlen z.A., Dingler A., and Mehnert W. Solid Lipid Nanoparticles (SLN)- ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika I. Systemeingeschaften, Herstellung und scaling up. Pharm. Ind. 59 (1997) 423-427
8. Westesen K., Siekmann B., and Koch M.H.J. Investigations on the physical state of lipid nanoparticles by synchrotron radiation x-ray diffraction. Int. J. Pharm. 93 (1997) 189-199
9. Mühlen z.A., Mühlen z.E., Niehaus E., and Mehnert W. Atomic force microscopy studies of solid lipid nanoparticles. Pharm. Res. 13 (1996) 1411-1416
10. Mühlen z.A., and Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie 53 (1998) 552
11. V. Jenning, Feste Lipid Nanopartikel als kolloidale Wirkstofftrager- systeme zur dermalen Applikation, PhD Thesis, Freie University of Berlin 1998
12. Freitas C., and Mu{double acute}ller R.H. Correlation between long-term stability of Solid Lipid Nanoparticles (SLN() and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm. 47 (1999) 125-132
13. Wissing S.A., and Mu{double acute}ller R.H. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int. J. Pharm. 242 (2002) 377-379
14. Wissing S.A., and Mu{double acute}ller R.H. The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles. Int. J. Pharm. 242 (2002) 373-375
15. Brittain H.G., and Fieses E.F. Effects of mechanical processing on phase composition. J. Pharm. Sci. 91 (2002) 1573-1580
16. Radomska A., Dobrucki R., and Mu{double acute}ller R.H. Chemical stability of the lipid matrices of Solid Lipid Nanoparticles (SLN)-development of an analytical method and determination of long-term stability. Pharmazie 54 (1999) 903-909
17. Garces R., and Mancha M. One-step lipid extraction from fresh plant tissues. Anal. Biochem. 211 (1993) 139-143
18. Mu{double acute}ller R.H., and Peters K. Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique. Int. J. Pharm. 160 (1998) 229-237
19. Freitas C., and Mu{double acute}ller R.H. Effect of light and temperature on zeta potential and physical stability in Solid Lipid Nanoparticles SLN™ dispersion. Int. J. Pharm. 168 (1998) 221-229
20. Lucks J.S., Mu{double acute}ller B.W., and Mu{double acute}ller R.H. Inorganic suspensions - interaction with salts and ionic surfactants. Int. J. Pharm. 58 (1990) 229-235
21. R.H. Mu{double acute}ller, J. S. Lucks (1996) European Patent 0605497
22. Carstensen H., Mu{double acute}ller B.W., and Mu{double acute}ller R.H. Adsorption of ethoxylated surfactants on nanoparticles. I. Characterization by hydrophobic interaction chromatography. Int. J. Pharm. (1991) 29-37
23. Hunter R.J. Foundations of colloidal science Vol. 1 (1986), Oxford University Press